Effect of schistosomal infection and of schistosomicidal drugs on the drug metabolizing enzymes of mouse liver.
D000814:Aniline Compounds / Q000378:metabolism; D000818:Animals; D000871:Anthelmintics / Q000494:pharmacology*; D000965:Antimony / Q000494:pharmacology; D000983:Antipyrine / Q000378:metabolism; D001557:Benzenesulfonates / Q000494:pharmacology; D003640:Dealkylation; D006591:Hexobarbital / Q000378:metabolism; D006900:Hydroxylation; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008154:Lucanthone / Q000494:pharmacology; D008297:Male; D051379:Mice; D008862:Microsomes, Liver / Q000201:enzymology; D009560:Niridazole / Q000494:pharmacology; D010084:Oxidation-Reduction; D010261:Paraoxon / Q000378:metabolism; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D012550:Schistosoma mansoni / Q000187:drug effects*; D012552:Schistosomiasis / Q000188:drug therapy / Q000201:enzymology*; D012556:Schistosomicides / Q000494:pharmacology / Q000627:therapeutic use; D013644:Tartrates / Q000494:pharmacology
D000814:Aniline Compounds; D000871:Anthelmintics; D001557:Benzenesulfonates; D004364:Pharmaceutical Preparations; D012556:Schistosomicides; D013644:Tartrates; D000965:Antimony; D006591:Hexobarbital; D008154:Lucanthone; D009560:Niridazole; D010261:Paraoxon; D000983:Antipyrine